IMCD N.V. (IMDZF)
| Previous Close | 168.35 |
| Open | 168.35 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 168.35 - 168.35 |
| 52 Week Range | 114.72 - 180.77 |
| Volume | |
| Avg. Volume | 5 |
| Market Cap | 9.583B |
| Beta (5Y Monthly) | 1.03 |
| PE Ratio (TTM) | 30.78 |
| EPS (TTM) | 5.47 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.42 (1.44%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
GlobeNewswireIMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
Photo_IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma Photographed from left to right:•Cristina Marti, Director API Sales and Strategy, IMCD Group•Gianluca Galimberti, General Manager, Cobapharma•Tess Hendriks, Legal Counsel M&A, IMCD Group•Fenna van Zanten, Director M&A, IMCD Group•Jose Alcover, Managing Director, IMCD Iberia & Maghreb ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and
Simply Wall St.IMCD N.V.'s (AMS:IMCD) Stock Has Fared Decently: Is the Market Following Strong Financials?
Most readers would already know that IMCD's (AMS:IMCD) stock increased by 9.5% over the past three months. Given that...
GlobeNewswireIMCD publishes convocation for its upcoming Annual General Meeting
IMCD_logo Logo IMCD N.V. ROTTERDAM, The Netherlands (2 April 2024, 18:00 hrs CEST) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, formulator of speciality chemicals and ingredients, today published the convocation and agenda for its Annual General Meeting of shareholders (AGM), which will be held on Tuesday 14 May 2024 at 14:00 CEST at the Mainport by Inntel Hotel, Schiedamsedijk 140, 3011 EN, in Rotterdam, the Netherlands. The convocation, agenda and further documenta
